Recap: GlaxoSmithKline Q1 Earnings


GlaxoSmithKline GSK reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.


GlaxoSmithKline beat estimated earnings by 15.79%, reporting an EPS of $0.88 versus an estimate of $0.76.

Revenue was up $2.89 billion from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 0.41% increase in the share price the next day.

Here's a look at GlaxoSmithKline's past performance:


Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate 0.65 0.81 0.57 0.61
EPS Actual 0.69 1.01 0.79 0.63
Revenue Estimate 12.79B 11.88B 10.54B 11.06B
Revenue Actual 12.84B 12.44B 11.33B 10.24B

To track all earnings releases for GlaxoSmithKline visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarningsNews